We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Motif Bio Plc | LSE:MTFB | London | Ordinary Share | GB00BVVT4H71 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.50 | 0.40 | 0.55 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
13/8/2018 19:13 | Could be a buy order filled or AMP selling | encarter | |
13/8/2018 17:17 | As I said other day it felt like someone was holding them down to bid the seller !! Hmmmmm naughty naughty | nico115 | |
13/8/2018 16:49 | 11 million sell?? | small crow | |
13/8/2018 09:29 | Yes price is creeping up. | encarter | |
13/8/2018 08:13 | Looking good for the week. | small crow | |
09/8/2018 14:26 | Look at MTFB offer ,if you want to really sell stock you DONT offer 350k in one lump..manipulated to take out a seller @amph? | nico115 | |
09/8/2018 08:52 | See new Proactiveinvestor interview with GL explaining the significance of the new patent filings on the period of exclusivity for Iclaprim. More often than not, secondary patent filings seem to offer only minimal additional protection, but in this case it sounds like it will provide a real barrier to entry for an additional 8 years or so. | timbo003 | |
09/8/2018 03:41 | Worth noting the FDA advisory committee's positive vote for Omadacycline in the treatment of ABSSSI. The share price performance for Paratek is not exactly encouraging. The market seems to have doubts about new antibiotics. | mirako | |
08/8/2018 16:11 | Patents registered in America are not worth a carrot. Morgan will agree with that statement. He and his Amphion business plan is still chasing down patent infringements with no hope of success. | hoggar | |
08/8/2018 11:59 | Motif Bio (MTFB) News Out Just Now | danieldanj | |
08/8/2018 07:46 | Great news re US patents, one step closer to its lucrative US approval and commercialisation. | rathean | |
07/8/2018 22:58 | told you clown this was going back to 20p... here it goes | ssrover | |
07/8/2018 19:18 | t-trader Todays close would seem to suggest it has broken down your lower trendline, this will become the barrier and we should break lower. My charting system has just posted a Sell and the RSI is weakening. I am looking for a level to buy but holding off as a break through 30p would indicate a drop to test 26p. | alaneagle | |
07/8/2018 14:34 | Back in with a sneaky 10k sub 30p as are a few others looking at the quick trades pushing the share price back up. Looking for a short tdrm capital gain on the back of NDA approval... just hoping they filled the paperwork out correctly, took them long enough :/ | rathean | |
27/7/2018 10:18 | Any early FDA signposting or a European application would see this return to mid-30s imo. I'm the meantime it's narrowing range trading is well set. | rathean | |
26/7/2018 10:02 | small crow, yes your correct with your observation, indeed it usually breaks out in the same direction as the initial movement. So as its in a long term rising trend, I would expect it to break upwards, but you just never know for sure. Fingers XXX | t-trader | |
26/7/2018 09:28 | re 2332: doesn't a pennant like that usually break in the direction of the previous break ie Upwards?? | small crow | |
26/7/2018 09:27 | Seems like a bargain price at the moment IMHO Hard to believe there is much downside from here, but who knows. Fingers crossed this is the bottom. | t-trader | |
26/7/2018 09:09 | Just added another 7500, very close to long term support level. | rathean | |
25/7/2018 12:50 | Time to buy back in. Bought 33,356 at 30.39p - hopefully this is strong support! | adorling | |
25/7/2018 11:05 | I agree, 31p should be the bottom, not sure the submission was ever going to move the share price north but FDA approval must do as is not a given. Other than that, I would think only a commercial deal will have that effect. The wait goes on | bowles22 | |
25/7/2018 10:58 | Were touching the bottom of the 2yr trend line now, so would expect it to bounce from here. Were also in a nicely formed wedge, so expect a breakout one way or another over the next few months (just hope it's upwards and not downwards). free stock charts from uk.advfn.com | t-trader | |
24/7/2018 16:33 | It's telling you that AMP have stock to dump. Once the have the share price will double imho. | encarter | |
24/7/2018 10:46 | lol, just telling me that we are waiting a while for positive news, imo | bountyhunter |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions